At a glance
ClinicalIndex Comparison RecordN/ACompleted· 50 enrolled
Drug / intervention
FULTIUM D3 VITAMIN D3dietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Scottish Vitamin D Intervention Study
In Brief
A clinical study evaluating FULTIUM D3 VITAMIN D3 for GENE EXPRESSION and Colorectal Cancer. Completed, enrolled 50 participants across 1 site.
Detailed Summary
AIMS To identify the underlying mechanism by which Vitamin D reduces colorectal cancer risk. OBJECTIVES To demonstrate the effects of vitamin D supplementation on serum vitamin D levels. To demonstrate dynamic changes in gene expression in response to vitamin D. To demonstrate the mechanism underlying the gene-environment interaction of vitamin D, susceptibility genetic variants (risk genes) and colorectal cancer.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsGENE EXPRESSION, Colorectal Cancer
CountriesUnited Kingdom
CollaboratorsCancer Research UK, Medical Research Council
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartMar 2014
Primary CompletionApr 2016
Study CompletionJul 2016
First PostedApr 2021
TodayJul 2026
First PostedApr 30, 2021
Enrollment StartMar 28, 2014
Primary CompletionApr 11, 2016
Study CompletionJul 11, 2016
TodayJul 2, 2026
Enrollment to primary: 2.0 yearsPosted 5.2 years ago
Interventions
FULTIUM D3 VITAMIN D3dietary
VITAMIN D3 SUPPLEMENT